Stuart Pearson

504 total citations
10 papers, 423 citations indexed

About

Stuart Pearson is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Stuart Pearson has authored 10 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Stuart Pearson's work include Estrogen and related hormone effects (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Endometriosis Research and Treatment (2 papers). Stuart Pearson is often cited by papers focused on Estrogen and related hormone effects (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Endometriosis Research and Treatment (2 papers). Stuart Pearson collaborates with scholars based in United Kingdom, United States and Poland. Stuart Pearson's co-authors include J. M. Fromson, Peter B. Nunn, P. L. Lantos, R.G. Hill, James F. Collins, Norman G. Bowery, Marian K. Rippy, Thomas J. Kuehl, Zining Wu and Per Stahl Skov and has published in prestigious journals such as Brain Research, Cellular and Molecular Life Sciences and Frontiers in Immunology.

In The Last Decade

Stuart Pearson

10 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Pearson United Kingdom 7 221 110 86 60 59 10 423
Mary Ann Alejandro United States 14 289 1.3× 257 2.3× 30 0.3× 32 0.5× 29 0.5× 18 636
Matthew C. Lorence United States 15 313 1.4× 486 4.4× 287 3.3× 53 0.9× 44 0.7× 20 1.1k
Michael R. Waterman United States 9 101 0.5× 225 2.0× 150 1.7× 36 0.6× 32 0.5× 10 487
Reuben Chayoth Israel 15 70 0.3× 339 3.1× 26 0.3× 68 1.1× 50 0.8× 47 768
Denis G. Williamson Canada 13 127 0.6× 201 1.8× 97 1.1× 19 0.3× 34 0.6× 52 485
William J. Driscoll United States 18 104 0.5× 389 3.5× 86 1.0× 73 1.2× 109 1.8× 41 703
Tamara L. Casebolt United States 9 116 0.5× 334 3.0× 34 0.4× 123 2.0× 59 1.0× 11 614
L. J. Roman United States 10 98 0.4× 330 3.0× 60 0.7× 31 0.5× 26 0.4× 15 760
Paulina Wlodawer Poland 14 91 0.4× 262 2.4× 88 1.0× 78 1.3× 218 3.7× 23 681
Jeffrey M. Voigt United States 15 76 0.3× 391 3.6× 147 1.7× 25 0.4× 35 0.6× 33 669

Countries citing papers authored by Stuart Pearson

Since Specialization
Citations

This map shows the geographic impact of Stuart Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Pearson more than expected).

Fields of papers citing papers by Stuart Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Pearson. The network helps show where Stuart Pearson may publish in the future.

Co-authorship network of co-authors of Stuart Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Pearson. A scholar is included among the top collaborators of Stuart Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Pearson. Stuart Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Macphee, Colin H., Xinzhong Dong, Peng Qi, et al.. (2024). Pharmacological blockade of the mast cell MRGPRX2 receptor supports investigation of its relevance in skin disorders. Frontiers in Immunology. 15. 1433982–1433982. 8 indexed citations
2.
Kuehl, Thomas J., et al.. (1997). O-076 Video mapping to assess efficacy of an antiestrogen (raloxifene) on spontaneous endometriosis in the rhesus monkey. Fertility and Sterility. 68. S38–S39. 2 indexed citations
3.
Rippy, Marian K., et al.. (1996). Identification of rhesus macaques with spontaneous endometriosis. Journal of Medical Primatology. 25(5). 346–355. 14 indexed citations
4.
Pearson, Stuart, et al.. (1985). Comparative toxicities of α- and β-N-oxalyl-l-α,β-diaminopropionic acids to rat spinal cord. Neuroscience Letters. 55(1). 89–94. 43 indexed citations
5.
Pearson, Stuart & Peter B. Nunn. (1981). The neurolathyrogen, β-N-oxalyl-L-α,β-diaminopropionic acid, is a potent agonist at ‘glutamate preferring’ receptors in the frog spinal cord. Brain Research. 206(1). 178–182. 63 indexed citations
6.
Pearson, Stuart, Peter B. Nunn, & N. Joan Abbott. (1979). High K+ content explains the abolition of the action potential in amphibian sciatic nerve in vitro byLathyrus sativus seed extract. Cellular and Molecular Life Sciences. 35(10). 1363–1364. 1 indexed citations
7.
Collins, James F., et al.. (1977). t-Butyl bicyclo phosphate: a convulsant and GABA antagonist more potent than bicuculline [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(2). 275P–276P. 6 indexed citations
8.
Bowery, Norman G., James F. Collins, R.G. Hill, & Stuart Pearson. (1976). GABA antagonism as a possible basis for the convulsant action of a series of bicyclic phosphorus esters [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(3). 435P–435P. 15 indexed citations
9.
Fromson, J. M., et al.. (1973). The Metabolism of Tamoxifen (I.C.I. 46,474) Part I : In Laboratory Animals. Xenobiotica. 3(11). 693–709. 157 indexed citations
10.
Fromson, J. M., et al.. (1973). The Metabolism of Tamoxifen (I.C.I. 46,474) Part II: In Female Patients. Xenobiotica. 3(11). 711–714. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026